Log in  First Connection?

MelanomaArchives

The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trial
Melanoma
 1 min.

 Published on 08/06/2026 |  Original article (Full-text)  | Timothy Beard et al. | Future Oncology 2026; 22(8): 933-938

Prospectively confirm use of the integrated 31-gene expression profile test (i31-SLNB) in patients with cutaneous melanoma to predict sentinel lymph node biopsy (SLNB) positivity and assess recurrence rates in those considered low risk by i31-SLNB who did not have an SLNB. Patients with T1–T4 tumors...

Systemic cardiac migration of perfluorocarbon liquid following unsuccessful endoresection of choroidal melanoma: a case report
Melanoma
 1 min.

 Published on 01/06/2026 |  Original article (Full-text)  | Tomislav Jukić et al. | Future Cardiology 2026; aop:10.1080/14796678.2026.2680047

Choroidal melanoma (CM) is the most common intraocular malignant tumor in adults, with a high rate of metastasis and mortality. This study reports a case of systemic cardiac migration of perfluorocarbon liquid (PFCL) following an unsuccessful endoresection of CM. A 61-year-old woman underwent gamma knife...

Machine learning-based prognostic prediction for cutaneous malignant melanoma patient survival
Melanoma
 1 min.

 Published on 25/05/2026 |  Original article (Full-text)  | Yuxin Wang et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2644385

Cutaneous malignant melanoma (CMM) is a highly malignant tumor that necessitates early diagnosis and precise survival prediction. The development of accurate prognostic models is essential for improving patient survival. This retrospective study analyzed data from 5979 CMM patients in the SEER database...

Artificial intelligence in retinoblastoma and uveal melanoma - a narrative review
Melanoma
 1 min.

 Published on 18/05/2026 |  Original article (Full-text)  | Bharat Gurnani et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2671252

Artificial intelligence (AI) is reshaping diagnostic paradigms across oncology. In ophthalmic oncology encompassing conditions like retinoblastoma and uveal melanoma, AI has immense potential due to the specialty's reliance on advanced imaging and the importance of early and accurate diagnosis. This...

Immunotherapy for patients with melanoma in East Asia: current evidence, future directions, and clinical implications
Melanoma
 1 min.

 Published on 11/05/2026 |  Original article (Full-text)  | Junjie Gu et al. | Expert opinion on biological therapy 2026; 26(5): 461-474

Melanomas cause the vast majority of skin-cancer related deaths, despite accounting for only around 2% of skin cancer cases. Moreover, due to genetic and environmental factors, the melanomas that predominate in East Asian populations, generally acral and mucosal melanomas, are extremely rare in Caucasian...

Histopathological characteristics of secondary enucleation after iodide-125 plaque radiotherapy in Chinese patients with uveal melanoma
Melanoma
 6 min.

 Published on 04/05/2026 |  Original article (Full-text)  | Haihan Zhang et al. | British Journal of Ophthalmology 2026; 110(5): 592-600

Data are available on reasonable request. The data underlying this article are available in the article and in its online supplementary material. More specific data in this article cannot be shared due to the privacy of individuals that participated in the study. Further information and requests for...